Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6811 AL 6825

Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies

Ciceri F, Rotllant D, Maes T.

Curr Pharm Des. 2017;23(5):839-857. doi: 10.2174/1381612823666170124121140.

Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease

Braidy N, Behzad S, Habtemariam S, Ahmed T, Daglia M, Nabavi SM, Sobarzo-Sanchez E, Nabavi SF.

CNS Neurol Disord Drug Targets. 2017;16(4):387-397. doi: 10.2174/1871527316666170328113309.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease

Li Y, Zhao J, Hölscher C.

CNS Drugs. 2017 Aug;31(8):639-652. doi: 10.1007/s40263-017-0451-y.

Recent Advances on the Role of Neurogenesis in the Adult Brain: Therapeutic Potential in Parkinson's and Alzheimer's Diseases

Radad K, Moldzio R, Al-Shraim M, Kranner B, Krewenka C, Rausch WD.

CNS Neurol Disord Drug Targets. 2017;16(7):740-748. doi: 10.2174/1871527316666170623094728.

Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs

Lazarevic-Pasti T, Leskovac A, Momic T, Petrovic S, Vasic V.

Curr Med Chem. 2017;24(30):3283-3309. doi: 10.2174/0929867324666170705123509.

Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies

Brodowicz J, Przegaliński E, Müller CP, Filip M.

Neurotox Res. 2018 Feb;33(2):474-484. doi: 10.1007/s12640-017-9798-6. Epub 2017 Aug 25.

[Memantine: from the original brand to generics]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.

Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review

Bansal R, Singh R.

Med Res Rev. 2018 Jul;38(4):1126-1158. doi: 10.1002/med.21458. Epub 2017 Jul 11.

Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease

Ji C, Xue GF, Li G, Li D, Hölscher C.

Rev Neurosci. 2016 Jan;27(1):61-70. doi: 10.1515/revneuro-2015-0021.

Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia

Szeto JY, Lewis SJ.

Curr Neuropharmacol. 2016;14(4):326-38. doi: 10.2174/1570159x14666151208112754.

Comorbidities Matter: A Call to Improve Care for Hospitalized Patients with Alzheimer's and Parkinson's Disease

DiBartolo MC.

J Gerontol Nurs. 2016 Feb;42(2):4-5. doi: 10.3928/00989134-20160113-01.

Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine

Nabavi SF, Braidy N, Habtemariam S, Sureda A, Manayi A, Nabavi SM.

Curr Top Med Chem. 2016;16(17):1910-5. doi: 10.2174/1568026616666160204121725.

Phage M13 for the treatment of Alzheimer and Parkinson disease

Messing J.

Gene. 2016 Jun 1;583(2):85-89. doi: 10.1016/j.gene.2016.02.005. Epub 2016 Feb 8.

Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases

Irwin MH, Moos WH, Faller DV, Steliou K, Pinkert CA.

Drug Dev Res. 2016 May;77(3):109-23. doi: 10.1002/ddr.21294. Epub 2016 Feb 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias